October 26, 2020
2 min watch
Save
Anti-VEGF research to look forward to at AAO 2020
Healio spoke with Rishi P. Singh, MD, staff surgeon at Cleveland Clinic Cole Eye Institute, associate professor of ophthalmology at Lerner College of Medicine and Healio/OSN Board Member, about what he’s looking forward to at AAO 2020, such as 10-year data from the Age-related Eye Disease Study (AREDS) 2 trial on dry AMD, important long-term data from the Protocol V study, data on newer molecules and more.
Click here to watch the next video in the series on using an evidence-based approach to choose anti-VEGF regimens for patients.
Published by:
Sources/Disclosures
Collapse
Disclosures:
Singh reports consulting for Alcon, Bausch + Lomb, Genentech, Novartis, Regeneron and Zeiss, and research grants from Aerie Pharmaceuticals, Apellis and Graybug.